Patricia Gallup also recently made the following trade(s): The company also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Tuesday, November 10th will be issued a dividend of $0.20 per share. This represents a…
BTC Health (ASX:BTC) signed a new exclusive distribution agreement with Exstent to sell its ExoVasc PEARS cardiac device in both Australia and India. The new agreement replaces an April 2024 deal and expands the partnership following a 20% revenue growth in…
TradingView INOVIO Pharmaceuticals, Inc. (INO) Plans Public Stock Offering INOVIO intends to sell shares of common stock in an underwritten public offering and may grant underwriters a 30-day option for up to 15% of the offered shares. Size and terms are…
EL PASO, Texas (KFOX14/CBS4) — Socorro Independent School District employees are likely to pay more for health insurance next year after voters rejected a tax proposal that district leaders said would have brought in new funding. SISD's board held a special meeting…
Latigo Biotherapeutics, Inc. (NASDAQ:LTGO - Get Free Report) traded down 22.4% during mid-day trading on Thursday. The stock traded as low as $10.24 and last traded at $10.89. 51,744 shares were traded during trading, a decline of 82% from the average session volume of 280,885 shares.
Posted by Michael Walen on Nov 6th, 2026 GRAIL (NASDAQ:GRAL) reported 4% revenue growth for the third quarter of 2026 as higher testing volumes were offset in part by lower prices, and said it expects a U.S. regulatory decision on its Galleri cancer screening…
Posted by Michael Walen on Nov 6th, 2026 Organogenesis (NASDAQ:ORGO) reported a 70% year-over-year decline in third-quarter net product revenue and lowered the upper end of its full-year revenue outlook as the skin substitute market recovered more slowly than management had anticipated.
Healthcare data analytics company Health Catalyst HCAT beat Wall Street’s revenue expectations in Q3 2026, but revenue fell by 26.3% year on year to $56.28 million. The company expects the full year’s revenue to be around $247.5 million, close to analysts’ consensus estimates. Its non-GAAP…
The Debt Settlement comprises $125,493.70 in accrued interest owing to holders of the Company's existing 12.0% unsecured convertible debentures and $110,414.90 in outstanding amounts payable to certain service providers. The issuance of the Settlement Shares remains subject to all requisite regulatory approvals, including…
Zimmer Biomet Holdings has an average rating of hold and mean price target of $105.75, according to analysts polled by FactSet. Price: 111.46, Change: +14.40, Percent Change: +14.84... Zimmer Biomet Holdings, Inc. Medical Equipment, Supplies & Distribution Evercore ISI Adjusts Price Target on Zimmer Biomet…
Hospitals, clinics, payers, med‑tech, telehealth, and healthcare services delivery.
An article joins this feed when it matches these terms. Each one is also a search of its own.